Testing is Appropriate at an Annual Health Exam: What, When, and WHY? - Frankly Speaking Ep 191

episode

Frankly Speaking About Family Medicine not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Frankly Speaking About Family Medicine

2026 ACC/AHA Dyslipidemia Guideline Review: Getting to the Heart of the Evidence - Frankly Speaking Ep 497 16 min · 10 Aug 2026

The Cannabis Conversation: Discussing the Risks with Adolescent Patients - Frankly Speaking Ep 496 13 min · 03 Aug 2026

Statins—Time to Stop the Worry! - Frankly Speaking Ep 495 11 min · 27 Jul 2026

Digital Dependence: Screening Adults for Screen Time - Frankly Speaking Ep 494 11 min · 20 Jul 2026

From Guidelines to Practice: Managing CKD in Primary Care - Frankly Speaking Ep 493 13 min · 13 Jul 2026

SPAN Small Changes to a Longer, Healthier Life - Frankly Speaking Ep 492 13 min · 06 Jul 2026

All episodes from Frankly Speaking About Family Medicine →

Report any issue

Source

Recorded28 Sep 2020

Publisherfeed.podbean.com ↗

Handlerec:9022723

Show notes

Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-191 Overview: Screening for asymptomatic conditions is an essential and important aspect of primary care. But what is the potential downstream impact to the patents and the healthcare system when low-risk individuals are screened? What are the benefits and the potential harms? Join us as we discuss a recent retrospective study on the downstream effects of low-value testing on low-risk people at their annual health exam and how this may impact your practice. Guest: Susan Feeney, DNP, FNP-BC Music Credit: Richard Onorato

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in